Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Concurrent Chemo-Radiotherapy in Unresectable Stage III NSCLC
NCT01218594Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2009
- Primary completion
- Dec 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01218594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218594.